coming soon2
Corplex P TM

The First FDA Cleared
Human Umbilical Cord-Derived Medical Device

StimLabs is the first and only company to receive a wound management 510(k) clearance for human birth tissue products. Corplex P's successful clearance was achieved by demonstrating the product’s safety and effectiveness through unique technology, the highest quality standards, and rigorous testing.

CP Vial Pile Portrai

Advantages of Corplex P1

Formatted as a particulate for the management of damaged or deficient tissue

Composed of a porous network of extracellular matrix components

Facilitates a moist wound environment through the regulation of moisture exchange

Corplex P, a human umbilical cord particulate device, is indicated for use in the management of the following wounds:

Partial & Full-thickness Wounds

Pressure Ulcers

Venous Ulcers

Diabetic Ulcers

Chronic Vascular Ulcers

Tunneling/Undermined Wounds

Surgical Wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence)

Trauma Wounds(abrasions, lacerations, partial-thickness burns, & skin tears)

Draining Wounds

Register for Launch Alerts

BE THE FIRST TO KNOW WHEN CORPLEX P IS AVAILABLE FOR YOUR PATIENTS!

Name(Required)

By submitting this form, you agree to inquiry-related or marketing communications from Stimlabs LLC.

1. Data on file. Patents: www.stimlabs.com/patents